FindTrial
Sign In

Artificial intelligence assisted analysis system for 68Ga-PSMA PET/CT

Artificial intelligence assisted analysis system for 68Ga-PSMA PET/CT

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400082890
Enrollment
Unknown
Registered
2024-04-10
Start date
2022-09-01
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

Gold Standard:Nuclear medicine radiologist's judgement
Index test:artificial intelligence (AI) model

Sponsors

Department of Nuclear Medicine, West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 95 Years

Inclusion criteria

Inclusion criteria: We collected images from individual patients who were suspected to have prostate cancer and underwent 68Ga-PSMA PET/CT between January 1st, 2022, and December 31th, 2023.

Exclusion criteria

Exclusion criteria: Then, cases with improper injection, improper imaging process, and poor image quality, the patients who had primary bone tumor and the ones did not undergo follow-up examinations were excluded as well.

Design outcomes

Primary

MeasureTime frame
Accuracy;sensitivity;—

Countries

China

Contacts

Public ContactHuawei Cai

West China Hospital

huawei.cai@wchscu.edu.cn+86 138 8071 1669

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026